Tenet Healthcare Reports Strong Q2 Earnings and Raises Full-Year Guidance
Tenet Healthcare (NYSE:THC) reported second-quarter earnings of $6.12 per share, surpassing the expected $4.26, with revenue reaching $5.63 billion against a forecast of $5.43 billion. The company raised its full-year guidance for 2026 to an EPS range of $20.30–$21.69 from the previous consensus estimate of $17.81 and lifted revenue expectations to between $21.9 billion and $22.5 billion. The results were driven by strong same-store revenue growth, disciplined cost management across its Hospital Operations and Ambulatory Care segments, as well as improved financial fundamentals highlighted in a recent credit rating upgrade from Moody’s. Tenet's performance contrasts with some sector peers like HCA Healthcare that have faced challenges due to an unfavorable payer mix. The positive results led to a 14.6% premarket rise for THC shares despite ongoing caution toward the hospital sector, though they remain below their 52-week high.
Tickers: $THC